InnovAge Holding Corp. Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations
InnovAge Holding Corp. (INNV) reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations of $33.84 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations · last filed 2026-09-09
- InnovAge Holding Corp. cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect continuing operations for the quarter ending 2025-09-30 was $3.10M.
- InnovAge Holding Corp. cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect continuing operations for the quarter ending 2024-09-30 was -$17.93M.
- InnovAge Holding Corp. cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect continuing operations for fiscal 2026 was $33.84M, a 311.02% increase from fiscal 2025.
- InnovAge Holding Corp. cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect continuing operations for fiscal 2025 was $8.23M.
- InnovAge Holding Corp. cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect continuing operations for fiscal 2024 was -$70.31M.
| Period end | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations 3 month | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations 6 month | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations 9 month | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations 12 month |
|---|---|---|---|---|
| 2026-06-30 | $33.84M 10-K · filed 2026-09-09 | |||
| 2026-03-31 | $31.49M 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | $19.16M 10-Q · filed 2026-02-03 | |||
| 2025-09-30 | $3.10M 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | $8.23M 10-K · filed 2026-09-09 | |||
| 2025-03-31 | $3.51M 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | -$10.87M 10-Q · filed 2026-02-03 | |||
| 2024-09-30 | -$17.93M 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | -$70.31M 10-K · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |